KARM- XVII
DRAFT AGENDA
Offline - Vega Hotel &Convention Center, Moscow, Izmailovskoe sh., 71, 3B.
Online broadcast is available on www.medkarm.ru
DAY 1
THURSDAY, JUNE 6, 2024
PRE-COURCES
Constructor Hall
- Real quality control
- FISH precursor of spermatozoa: Pro et contra
- IVM - how I do it.
GYN-KARM
Kandinsky Hall
- Scars on the uterus – pregnancy and childbirth
- Treatment of polycystic ovary syndrome: from observation to action
DAY 2
FRIDAY, JUNE 7, 2024
Surikov-Vastensov Hall
- To wash or not to wash? Pro et contra
- Chronic endometritis through the eyes of a reproductologist
- Endometriosis: curb or curb? Pro et contra
- Adenomyosis and infertility
LEGAL ASPECTS OF REPRODUCTION.
ROUND TABLE DISCUSSION
- informational voluntary consent at assisted reproductive technologies (ART) and all about them (how to write, what to write, etc.)
- informational voluntary consent at preimplantation genetic testing. Contractual relations (all about contracts)
- Dietary supplements and of label in ART: how to apply and whether to apply
- Definition of ART Transfer of donor embryos from patients over 35 years.
- Disposal of embryos and informational voluntary consent.
DAY 3
SATURDAY, JUNE 8, 2024
Surikov-Vastensov Hall
- Psychology in reproduction
- Hormones
- "Cofactors" in reproduction. Are "smart" molecules really smart?
- Embryology. Adverse embryological outcomes of ART programs
DAY 4
SUNDAY, JUNE 9, 2024
Surikov-Vastensov Hall
- Physician's brand: Pros and cons
- Andrology
- Genetics
- Complex cases
M-KARM CONFERECES
This is a congress for phisicians and scientists united in the fight against infertility.
OUR PRINCIPLES
Study, understand, comprehend. The conference is based on the principles of objective science, evidence-based medicine and freedom of speech.
SPHERES OF OUR INTERESTS
Reproductology and andrology, oncofertility, genetics and epigenetics, fundamental and clinical embryology, cell biology
SCIENTIFIC REPORTS
- The reports can be based on original data, be reviewal, analytical, critical - but in any case, should have valuable scientific or medical content;
- Commercial reports and slides are prohibited;
- Commercial designations of drugs are possible, but if it is necessary within the meaning, and not for advertising;
- Conflicts of interest are possible, but should be clearly indicated.
QUESTIONS & DISCUSSIONS
Any questions and comments, with the exception of offensive, commercial and lying outside the topics of the conference, are allowed and welcomed.